MARKET

PGNX

Progenics Pharm
PGNX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-5.1199
9.55
11.60
355,046,195.30
About PGNX
Progenics Pharmaceuticals, Inc. is engaged in developing medicines and other products for targeting and treating cancer. The Company's pipeline includes therapeutic agents designed to target cancer (AZEDRA and 1095); prostate specific membrane antigen (PSMA)-targeted imaging agents for prostate cancer (1404 and PyL), and imaging analysis tools. It also includes commercial product, RELISTOR (methylnaltrexone bromide) for opioid-induced constipation. AZEDRA is a radiotherapeutic product candidate in development as a treatment for malignant and/or recurrent pheochromocytoma and paraganglioma, rare tumors found in the adrenal glands and outside of the adrenal glands, respectively. RELISTOR is a treatment for opioid induced constipation. PyL is a clinical-stage, fluorinated PSMA-targeted Positron Emission Topography (PET) imaging agent for prostate cancer. PSMA TTC is a thorium-227 labeled PSMA-targeted antibody therapeutic.
More

PGNX News

More
Lantheus Holdings Inc (LNTH) Q2 2020 Earnings Call Transcript
Joining me today is our President and CEO, Mary Anne Heino, and our CFO, Bob Marshall. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those i
Motley Fool · 5d ago
Lantheus Completes Merger with Progenics
Business Wire · 06/22 12:00
Independent Bank Group Set to Join S&P SmallCap 600
PR Newswire · 06/17 22:33
S&P Dow Jones Indices Reports 'Independent Bank Group Set to Join S&P SmallCap 600'
https://us.spindices.com/documents/indexnews/announcements/20200617-1167762/1167762_6independent6progenics.pdf?force_download=true
Benzinga · 06/17 21:35
Progenics Stockholders Approve Merger with Lantheus
GlobeNewswire · 06/16 21:05
Lantheus shareholders back stock issuance in Progenics tie-up
Seeking Alpha - Article · 06/16 20:26
Progenics Shareholders Approve The Proposed Merger With Lantheus
Benzinga · 06/16 20:09
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
PR Newswire · 05/28 00:53

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Progenics Pharm stock information, including NASDAQ:PGNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGNX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PGNX stock methods without spending real money on the virtual paper trading platform.